---
figid: PMC7368652__gr3_lrg
figlink: pmc/articles/PMC7368652/figure/f0015/
number: Fig. 3
caption: The role of phosphorylated GSK3β on polycystin-1/2 mutation of polycystic
  kidney disease. MIF stimulates cyst initiation and expansion via p-ERK/mTOR mediated
  cell proliferation pathway. GSK3β inhibitor (TDZD-8) or berberine may decrease renal
  cell proliferation and cyst expansion via p-ERK/p70-S6/c-Myc/Cyclin-D1/β-catenin
  modulation. From the macrophage aspect, high level of MIF in cyst modulate PI3K/Akt/GSK3β/MCP-1
  axis and promotes renal tubule cell proliferation and cyst expansion. Phosphorylated
  GSK3β (inactive form) results in MCP-1 production and β-catenin activation during
  the process of vascular remodeling and aneurysm. M1/M2 macrophages participates
  in different stages of aneurysm development. Long-term lithium treatment may influence
  podocyte cell cycle and renal function by GSK3β suppression (phosphorylated form).
  GSK3β degradation by microRNA-92a triggers podocyte re-entry cell cycle and renal
  failure via Ajuba and YAP/TAZ signal pathway.
pmcid: PMC7368652
papertitle: GSK3 modulation in acute lung injury, myocarditis and polycystic kidney
  disease-related aneurysm.
reftext: Wei-Lun Liu, et al. Biochim Biophys Acta Mol Cell Res. 2020 Nov;1867(11):118798-118798.
pmc_ranked_result_index: '14834'
pathway_score: 0.7713129
filename: gr3_lrg.jpg
figtitle: Phosphorylated GSK3B on polycystin-1/2 mutation of polycystic kidney disease
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7368652__gr3_lrg.html
  '@type': Dataset
  description: The role of phosphorylated GSK3β on polycystin-1/2 mutation of polycystic
    kidney disease. MIF stimulates cyst initiation and expansion via p-ERK/mTOR mediated
    cell proliferation pathway. GSK3β inhibitor (TDZD-8) or berberine may decrease
    renal cell proliferation and cyst expansion via p-ERK/p70-S6/c-Myc/Cyclin-D1/β-catenin
    modulation. From the macrophage aspect, high level of MIF in cyst modulate PI3K/Akt/GSK3β/MCP-1
    axis and promotes renal tubule cell proliferation and cyst expansion. Phosphorylated
    GSK3β (inactive form) results in MCP-1 production and β-catenin activation during
    the process of vascular remodeling and aneurysm. M1/M2 macrophages participates
    in different stages of aneurysm development. Long-term lithium treatment may influence
    podocyte cell cycle and renal function by GSK3β suppression (phosphorylated form).
    GSK3β degradation by microRNA-92a triggers podocyte re-entry cell cycle and renal
    failure via Ajuba and YAP/TAZ signal pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MIF
  - AKT2
  - AKT3
  - AKT1
  - MAPK3
  - MAPK1
  - EIF2AK3
  - MTOR
  - GSK3B
  - PCSK1
  - AJUBA
  - SOST
  - CCL2
  - MYC
  - IL23A
  - TAZ
  - YY1AP1
  - CCND1
  - CTNNB1
  - PTK2
genes:
- word: MIF
  symbol: MIF
  source: hgnc_symbol
  hgnc_symbol: MIF
  entrez: '4282'
- word: РІЗК/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: РІЗК/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: РІЗК/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: p-ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: p-ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: p-ERK
  symbol: PERK
  source: hgnc_alias_symbol
  hgnc_symbol: EIF2AK3
  entrez: '9451'
- word: p-ERK↑
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: p-ERK↑
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: p-GSK3B
  symbol: GSK3B
  source: hgnc_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: PC1/PC2mutation
  symbol: PC1
  source: hgnc_alias_symbol
  hgnc_symbol: PCSK1
  entrez: '5122'
- word: PC1/
  symbol: PC1
  source: hgnc_alias_symbol
  hgnc_symbol: PCSK1
  entrez: '5122'
- word: Ajuba
  symbol: AJUBA
  source: hgnc_symbol
  hgnc_symbol: AJUBA
  entrez: '84962'
- word: p-ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: p-ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: p-ERK
  symbol: PERK
  source: hgnc_alias_symbol
  hgnc_symbol: EIF2AK3
  entrez: '9451'
- word: SOST
  symbol: SOST
  source: hgnc_symbol
  hgnc_symbol: SOST
  entrez: '50964'
- word: МСР-1
  symbol: MCP-1
  source: hgnc_alias_symbol
  hgnc_symbol: CCL2
  entrez: '6347'
- word: с-Мус
  symbol: c-Myc
  source: hgnc_alias_symbol
  hgnc_symbol: MYC
  entrez: '4609'
- word: IL-23
  symbol: IL-23
  source: hgnc_alias_symbol
  hgnc_symbol: IL23A
  entrez: '51561'
- word: TAZ
  symbol: TAZ
  source: hgnc_symbol
  hgnc_symbol: TAZ
  entrez: '6901'
- word: YAP/TAZ
  symbol: TAZ
  source: hgnc_symbol
  hgnc_symbol: TAZ
  entrez: '6901'
- word: YAP/TAZ
  symbol: YAP
  source: hgnc_alias_symbol
  hgnc_symbol: YY1AP1
  entrez: '55249'
- word: YAP/
  symbol: YAP
  source: hgnc_alias_symbol
  hgnc_symbol: YY1AP1
  entrez: '55249'
- word: Cyclin-D1
  symbol: Cyclin-D1
  source: bioentities_symbol
  hgnc_symbol: CCND1
  entrez: '595'
- word: B-catenin
  symbol: BCATENIN
  source: bioentities_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: B-catenin↑
  symbol: BCATENIN
  source: bioentities_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: B-catenin
  symbol: BCATENIN
  source: bioentities_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: FAK
  symbol: FAK
  source: hgnc_alias_symbol
  hgnc_symbol: PTK2
  entrez: '5747'
chemicals: []
diseases: []
---
